Brief Title: Mood Disorders Bladder Cancer

PRIMARY OUTCOMES

Primary Outcome 1 - Measure: Severity of depression in bladder cancer patients and their caregivers: Patient-Health Questionnaire-9

Primary Outcome 1 - Timeframe: Data will be assessed through study completion, on average one year

Primary Outcome 2 - Measure: Severity of anxiety in bladder cancer patients and their caregivers: Generalized Anxiety Disorder-7

Primary Outcome 2 - Timeframe: Data will be assessed through study completion, on average one year

Primary Outcome 3 - Measure: Health-related quality of life in bladder cancer patients and their caregivers: Short Form-12

Primary Outcome 3 - Timeframe: Data will be assessed through study completion, on average one year

Primary Outcome 4 - Measure: Financial Toxicity in bladder cancer patients and their caregivers

Primary Outcome 4 - Timeframe: Data will be assessed through study completion, on average one year

CONDITION

• Bladder Cancer

ELIGIBILITY

Inclusion Criteria:
Patients or caregiver of patient with a histologic diagnosis of bladder cancer of the following subtypes, urothelial carcinoma, adenocarcinoma, or squamous cell carcinoma, within 24 months of survey administration and received treatment at the University of Kansas Health System

- ≥ 18 years of age

- Have a patient-designated primary informal/family caregiver

- Able to speak and read English

- Willing and able to provide informed consent

- Functioning telephone number or access to one
Exclusion Criteria:
Patients or caregivers of patients with metastatic bladder cancer

- Patients who are unable to designate a primary caregiver

- Patients and caregivers who do not both consent to study participation

Gender: All

Minimum Age: 18 Years

Maximum Age: N/A

Healthy Volunteers: N/A

OFFICIAL INFORMATION

Name: N/A

Role: N/A

Affiliation: N/A

Overall Contact

Name: N/A

Phone: 913-574-0847

Email: adahlgren@kumc.edu

LOCATION